SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-015353
Filing Date
2016-05-03
Accepted
2016-05-03 13:38:09
Documents
58
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aeri331201610q.htm 10-Q 665035
2 EXHIBIT 31.1 aeri3312016ex311.htm EX-31.1 16389
3 EXHIBIT 31.2 aeri3312016ex312.htm EX-31.2 16492
4 EXHIBIT 32.1 aeri3312016ex321.htm EX-32.1 10014
5 EXHIBIT 32.2 aeri3312016ex322.htm EX-32.2 9962
  Complete submission text file 0001628280-16-015353.txt   3992839

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aeri-20160331.xml EX-101.INS 837650
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20160331.xsd EX-101.SCH 32843
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20160331_cal.xml EX-101.CAL 51370
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20160331_def.xml EX-101.DEF 115951
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20160331_lab.xml EX-101.LAB 435227
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20160331_pre.xml EX-101.PRE 238954
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 161614721
SIC: 2836 Biological Products, (No Diagnostic Substances)